Test Price
2,800 AED✅ Home Collection Available
KCNB1 Gene Early Infantile Epileptic Encephalopathy Type 26 Genetic Test in UAE – 2,800 AED – DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity through ISO 9001:2015 certified NGS laboratory processing (Credential: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold‑chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post‑test telephonic consultation with a DHA‑licensed specialist for result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The KCNB1 Gene Early Infantile Epileptic Encephalopathy Type 26 Genetic Test is a definitive molecular diagnostic tool that identifies pathogenic variants in the KCNB1 gene, enabling precise clinical management for infants with refractory seizures and neurodevelopmental delay. Delivered via Next‑Generation Sequencing (NGS) with Sanger confirmation, this UAE‑based service ensures a 3–4 week turnaround and clinical‑grade results.
| Feature | Our Test (KCNB1 NGS) | Closest Alternative (Panel/Exome) |
|---|---|---|
| Precision | 99.9% single‑gene resolution with deep coverage | Multi‑gene panel may miss deep intronic/copy‑number variants |
| Methodology | NGS with Sanger confirmation | WES/WGS; longer interpretation time and incidental findings risk |
| Speed | 3–4 weeks from sample receipt | Often 6–8 weeks for whole‑exome reporting |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize the importance of a definitive molecular diagnosis for early infantile epileptic encephalopathy. This test provides precise information to guide targeted therapies and family counseling. Always integrate genetic findings with clinical and EEG data for optimal patient management.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication Warning
Do not discontinue prescribed anti‑epileptic medication or alter dosing without consulting your doctor. Abrupt changes can provoke severe, life‑threatening seizures. Always seek medical advice before making any modifications.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: This test is not intended for asymptomatic individuals without clinical suspicion; mandatory pre‑test genetic counselling (pedigree mapping) is required.
- ER Red Flags: Seek immediate emergency care if your infant experiences prolonged seizures (>5 minutes), respiratory distress, cyanosis, or loss of consciousness.
- Do not use genetic testing as a substitute for acute neurological evaluation.
Patient FAQ & Clinical Guidance
1. What is the KCNB1 gene test used for in early infantile epileptic encephalopathy?
This test identifies pathogenic KCNB1 mutations causing early infantile epileptic encephalopathy type 26, guiding targeted therapy and prognosis. It provides a definitive molecular diagnosis to inform personalized treatment strategies.
2. How should I prepare my child for the blood draw and genetic testing?
Preparation includes a mandatory genetic counselling session to create a detailed pedigree chart; no fasting is required. The sample is a simple peripheral blood draw, which can be performed at our facility or via our premium home collection service.
3. How long until I receive results, and what does the process involve?
Turnaround time is 3–4 weeks from sample arrival. After analysis, we provide a telephonic clinical consultation to explain the findings and discuss next steps in care.
UAE Regulatory & Data Privacy Adherence
This clinical test operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and stored securely within the UAE. Clinical safety and patient consent follow the standards set by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your privacy and safety are our utmost priority.
Clinical & Logistical Metadata
| Test Name | KCNB1 Gene Early Infantile Epileptic Encephalopathy Type 26 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks from sample receipt |
| Sample Type / Matrix | Whole Blood (EDTA) – Peripheral Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | G40.4 |
| LOINC Code | 82322-2 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians